The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth

Background: The Navigation Guide methodology was developed to meet the need for a robust method of systematic and transparent research synthesis in environmental health science. We conducted a case study systematic review to support proof of concept of the method. Objective: We applied the Navigation Guide systematic review methodology to determine whether developmental exposure to perfluorooctanoic acid (PFOA) affects fetal growth in humans. Methods: We applied the first 3 steps of the Navigation Guide methodology to human epidemiological data: 1) specify the study question, 2) select the evidence, and 3) rate the quality and strength of the evidence. We developed a protocol, conducted a comprehensive search of the literature, and identified relevant studies using prespecified criteria. We evaluated each study for risk of bias and conducted meta-analyses on a subset of studies. We rated quality and strength of the entire body of human evidence. Results: We identified 18 human studies that met our inclusion criteria, and 9 of these were combined through meta-analysis. Through meta-analysis, we estimated that a 1-ng/mL increase in serum or plasma PFOA was associated with a –18.9 g (95% CI: –29.8, –7.9) difference in birth weight. We concluded that the risk of bias across studies was low, and we assigned a “moderate” quality rating to the overall body of human evidence. Conclusion: On the basis of this first application of the Navigation Guide systematic review methodology, we concluded that there is “sufficient” human evidence that developmental exposure to PFOA reduces fetal growth. Citation: Johnson PI, Sutton P, Atchley DS, Koustas E, Lam J, Sen S, Robinson KA, Axelrad DA, Woodruff TJ. 2014. The Navigation Guide—evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect 122:1028–1039; http://dx.doi.org/10.1289/ehp.1307893

[1]  Gerald L Kennedy,et al.  The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. , 2004, Toxicology.

[2]  Carlijn R Hooijmans,et al.  Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed , 2010, Laboratory animals.

[3]  Mark J. Strynar,et al.  Polyfluorinated compounds: past, present, and future. , 2011, Environmental science & technology.

[4]  M. Mcgeehin,et al.  Maternal Concentrations of Polyfluoroalkyl Compounds during Pregnancy and Fetal and Postnatal Growth in British Girls , 2012, Environmental health perspectives.

[5]  E. Ha,et al.  Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes , 2012, PloS one.

[6]  M. Ritskes-Hoitinga,et al.  A Gold Standard Publication Checklist to Improve the Quality of Animal Studies, to Fully Integrate the Three Rs, and to Make Systematic Reviews More Feasible , 2010, Alternatives to laboratory animals : ATLA.

[7]  J. DeWitt,et al.  Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA? , 2010, Journal of immunotoxicology.

[8]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[9]  Reiko Kishi,et al.  Correlations between Prenatal Exposure to Perfluorinated Chemicals and Reduced Fetal Growth , 2008, Environmental health perspectives.

[10]  M. Longnecker,et al.  Perfluorinated compounds in relation to birth weight in the Norwegian Mother and Child Cohort Study. , 2012, American journal of epidemiology.

[11]  P. Gluckman,et al.  Developmental Origins of Health and Disease: List of contributors , 2006 .

[12]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[13]  Christopher J. Portier,et al.  IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS PReAMBLe , 2011 .

[14]  M. Glass,et al.  Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences , 2007, British journal of pharmacology.

[15]  A. Calafat,et al.  Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). , 2007, Environmental science & technology.

[16]  S. Lazic,et al.  A call for transparent reporting to optimize the predictive value of preclinical research , 2012, Nature.

[17]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[18]  Anna Beronius,et al.  Facilitating the use of non‐standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting , 2014, Journal of applied toxicology : JAT.

[19]  Diana Petitti,et al.  Update on the Methods of the U.S. Preventive Services Task Force: Estimating Certainty and Magnitude of Net Benefit , 2007, Annals of Internal Medicine.

[20]  Joseph K McLaughlin,et al.  Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. , 2008, American journal of epidemiology.

[21]  D. Moher,et al.  Chapter 10: Addressing reporting biases , 2011 .

[22]  Kennon Heard,et al.  Emergency medicine animal research: does use of randomization and blinding affect the results? , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[23]  Gerald L Kennedy,et al.  Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. , 2005, Toxicology.

[24]  Douglas G Altman,et al.  How to obtain the P value from a confidence interval , 2011, BMJ : British Medical Journal.

[25]  T. Arbuckle,et al.  Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. , 2013, International journal of hygiene and environmental health.

[26]  K. Teo,et al.  Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. , 2008, Environmental research.

[27]  M. Cogswell,et al.  High and Low Hemoglobin Levels During Pregnancy: Differential Risks for Preterm Birth and Small for Gestational Age , 2000, Obstetrics and gynecology.

[28]  Jørn Olsen,et al.  Perfluorinated Chemicals and Fetal Growth: A Study within the Danish National Birth Cohort , 2007, Environmental health perspectives.

[29]  M. Macleod,et al.  Improving the translational hit of experimental treatments in multiple sclerosis , 2010, Multiple sclerosis.

[30]  Patrice Sutton,et al.  An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.

[31]  D. Savitz,et al.  Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.

[32]  U. Dirnagl,et al.  Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality , 2008, Stroke.

[33]  Denise O'Connor,et al.  Chapter 5: Defining the review question and developing criteria for including studies , 2008 .

[34]  Midori Yoshida,et al.  Effects of perfluorooctanoic acid (PFOA) exposure to pregnant mice on reproduction. , 2010, The Journal of toxicological sciences.

[35]  D. Knapen,et al.  Structure-activity relationship assessment of four perfluorinated chemicals using a prolonged zebrafish early life stage test. , 2011, Chemosphere.

[36]  J. Giesy,et al.  Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. , 2011, Environmental science & technology.

[37]  F. Shofer,et al.  The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. , 2009, Reproductive toxicology.

[38]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[39]  D. Savitz,et al.  Perfluorooctanoic Acid Exposure and Pregnancy Outcome in a Highly Exposed Community , 2012, Epidemiology.

[40]  Douglas G. Altman,et al.  Chapter 9: Analysing Data and Undertaking Meta-Analyses , 2008 .

[41]  D. Savitz,et al.  Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. , 2009, American journal of epidemiology.

[42]  A. Calafat,et al.  Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. , 2011, Environmental science & technology.

[43]  Ulrich Dirnagl,et al.  Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench , 2009, Stroke.

[44]  K. Kannan,et al.  Distribution of perfluorochemicals between sera and milk from the same mothers and implications for prenatal and postnatal exposures. , 2011, Environmental pollution.

[45]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[46]  R. G. York,et al.  Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance. , 2010, Toxicology.

[47]  T. Woodruff,et al.  Environmental Chemicals in Pregnant Women in the United States: NHANES 2003–2004 , 2011, Environmental health perspectives.

[48]  D. Altman,et al.  Chapter 8: Assessing risk of bias in included studies , 2008 .

[49]  P. Steer,et al.  Relation between maternal haemoglobin concentration and birth weight in different ethnic groups , 1995, BMJ.

[50]  A. Azzalini,et al.  Distributions generated by perturbation of symmetry with emphasis on a multivariate skew t‐distribution , 2003, 0911.2342.

[51]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  Ord,et al.  Guidelines for Developmental Toxicity Risk Assessment , 2014 .

[53]  Ian T Cousins,et al.  Sources, fate and transport of perfluorocarboxylates. , 2006, Environmental science & technology.

[54]  Ord,et al.  Guidelines for Reproductive Toxicity Risk Assessment , 2014 .

[55]  S. Kennedy,et al.  Pipping success and liver mRNA expression in chicken embryos exposed in ovo to C8 and C11 perfluorinated carboxylic acids and C10 perfluorinated sulfonate. , 2009, Toxicology letters.

[56]  T. Halldorsson,et al.  Prenatal Exposure to Perfluorooctanoate and Risk of Overweight at 20 Years of Age: A Prospective Cohort Study , 2012, Environmental health perspectives.

[57]  R. Luebke,et al.  Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. , 2009, Critical reviews in toxicology.

[58]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[59]  T. Fletcher,et al.  The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. , 2011, Environmental research.

[60]  Joel Lexchin,et al.  Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. , 2011, JAMA.

[61]  G. Olsen,et al.  Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. , 2009, Reproductive toxicology.

[62]  T. Slotkin,et al.  Neurobehavioral teratogenicity of perfluorinated alkyls in an avian model. , 2010, Neurotoxicology and teratology.

[63]  M. Beckmann,et al.  Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study , 2007, International archives of occupational and environmental health.

[64]  Roger G Perkins,et al.  The Toxicology of Perfluorooctanoate , 2004, Critical reviews in toxicology.

[65]  J. Ioannidis,et al.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.

[66]  G. Donnan,et al.  Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. , 2007, Brain : a journal of neurology.

[67]  M. A. Mohd,et al.  Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.

[68]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[69]  D. Savitz,et al.  Relationship of Perfluorooctanoic Acid Exposure to Pregnancy Outcome Based on Birth Records in the Mid-Ohio Valley , 2012, Environmental health perspectives.

[70]  D. Savitz.  Guest Editorial: Biomarkers of Perfluorinated Chemicals and Birth Weight , 2007, Environmental health perspectives.

[71]  Rolf U. Halden,et al.  Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth , 2007, Environmental health perspectives.

[72]  D. Howells,et al.  Evidence-based translational medicine. , 2013, Stroke.

[73]  David W Howells,et al.  Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias , 2004, Stroke.

[74]  Pim de Voogt,et al.  Environmental and toxicity effects of perfluoroalkylated substances. , 2003, Reviews of environmental contamination and toxicology.

[75]  D. Savitz.  Biomarkers of Perfluorinated Chemicals and Birth Weight , 2007 .

[76]  Douglas G Altman,et al.  How to obtain the confidence interval from a P value , 2011, BMJ : British Medical Journal.

[77]  Tracey J. Woodruff,et al.  The Navigation Guide Systematic Review Methodology: A Rigorous and Transparent Method for Translating Environmental Health Science into Better Health Outcomes , 2014, Environmental health perspectives.

[78]  B. Koletzko,et al.  Pre- and postnatal exposure to perfluorinated compounds (PFCs). , 2010, Environmental science & technology.

[79]  Gloria B Post,et al.  Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. , 2012, Environmental research.

[80]  Yoichi Kawashima,et al.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.

[81]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[82]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[83]  C. Lau,et al.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[84]  M. Macleod,et al.  Preclinical studies of human disease: time to take methodological quality seriously. , 2011, Journal of molecular and cellular cardiology.

[85]  J. Higgins,et al.  Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. , 2007, International journal of epidemiology.

[86]  M. Lopez-Espinosa,et al.  Relationships of Perfluorooctanoate and Perfluorooctane Sulfonate Serum Concentrations between Mother–Child Pairs in a Population with Perfluorooctanoate Exposure from Drinking Water , 2012, Environmental health perspectives.

[87]  J. Martin,et al.  Births: final data for 2010. , 2012, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[88]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[89]  R. Marcos,et al.  The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies. , 2013 .

[90]  Paula I. Johnson,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Integration of Animal and Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[91]  A. Calafat,et al.  Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[92]  S. Dagnino,et al.  Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatchlings. , 2012, Toxicology.

[93]  M. Dalgaard,et al.  Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. , 2008, Toxicology.

[94]  Andrew A. Rooney,et al.  Forest Plot Viewer: a new graphing tool. , 2011, Epidemiology.

[95]  S. Fenton,et al.  Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. , 2009, Reproductive toxicology.

[96]  R. E. Staples,et al.  The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[97]  N. Cherry,et al.  Maternal exposure to perfluorinated acids and fetal growth , 2010, Journal of Exposure Science and Environmental Epidemiology.

[98]  S. Fenton,et al.  Endocrine disrupting properties of perfluorooctanoic acid , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[99]  A. A. Jensen,et al.  Emerging endocrine disrupters: perfluoroalkylated substances. , 2008, International journal of andrology.

[100]  Paula I. Johnson,et al.  The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.

[101]  Yang Liu,et al.  Disturbance of perfluorooctanoic acid on development and behavior in Drosophila larvae , 2010, Environmental toxicology and chemistry.

[102]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[103]  A. Arukwe,et al.  Endocrine and developmental effects in Atlantic salmon (Salmo salar) exposed to perfluorooctane sulfonic or perfluorooctane carboxylic acids. , 2012, Aquatic toxicology.

[104]  Sara Negri,et al.  Prenatal Exposure to PFOS or PFOA Alters Motor Function in Mice in a Sex-Related Manner , 2011, Neurotoxicity Research.

[105]  S. Campbell.  Fetal growth. , 1974, Clinics in obstetrics and gynaecology.

[106]  P. Santaguida,et al.  Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions , 2012 .

[107]  Gordon H Guyatt,et al.  GRADE guidelines: 9. Rating up the quality of evidence. , 2011, Journal of clinical epidemiology.

[108]  T. Woodruff,et al.  Instruments for Assessing Risk of Bias and Other Methodological Criteria of Published Animal Studies: A Systematic Review , 2013, Environmental health perspectives.

[109]  Sergio Sismondo,et al.  Industry sponsorship and research outcome. , 2012, The Cochrane database of systematic reviews.

[110]  Rolf U Halden,et al.  Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. , 2007, Environmental science & technology.

[111]  John W. Froehlich,et al.  Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.

[112]  C. Lau,et al.  Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life , 2009, Molecular and Cellular Endocrinology.

[113]  A. Calafat,et al.  Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. , 2009, Reproductive toxicology.

[114]  C. Lau,et al.  Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[115]  L. Rylander,et al.  Determinants of maternal and fetal exposure and temporal trends of perfluorinated compounds , 2013, Environmental Science and Pollution Research.

[116]  A. Calafat,et al.  Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[117]  G. Guyatt,et al.  The GRADE approach and Bradford Hill's criteria for causation , 2010, Journal of Epidemiology & Community Health.

[118]  Julian P T Higgins,et al.  Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales , 2008, Statistics in medicine.

[119]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[120]  D. Bellinger.  Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factors. , 2012, Neurotoxicology.

[121]  A. Calafat,et al.  Gestational and Chronic Low-Dose PFOA Exposures and Mammary Gland Growth and Differentiation in Three Generations of CD-1 Mice , 2011, Environmental health perspectives.

[122]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[123]  GA. Agency for Toxic Substances and Disease Registry. , 2022 .

[124]  >Enid Gilbert-Barness.  DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE , 2007 .

[125]  P. Schlattmann,et al.  Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.